Stock Screener App

Frei -

Installieren

11.90

7.55% -0.9534

Monte Rosa Therapeutics Inc (GLUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GLUE? Forum Prognose

Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	72.69% 23.19	84.93	60.65	9.216	4.695
Operating Expenses	5.25% 38.75	40.89	47.64	35.74	37.34
Benefits Costs and Expenses	7.88% 34.29	37.22	45.05	33.00	34.75
Costs And Expenses	7.88% 34.29	37.22	45.05	33.00	34.75
Operating Income/Loss	135.32% -15.55	44.04	13.00	-26.53	-32.64
Nonoperating Income/Loss	21.44% 4.458	3.671	2.597	2.739	2.584
Income/Loss From Continuing Operations Before Tax	123.26% -11.10	47.71	15.60	-23.79	-30.06
Income Tax Expense/Benefit	45.86% 1.199	0.822	2.164	0.071	0.252
Income/Loss From Continuing Operations After Tax	126.22% -12.29	46.88	13.44	-23.86	-30.31
Net Income/Loss	126.22% -12.29	46.88	13.44	-23.86	-30.31
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.05% 82.19	82.15	2.7364	82.01	71.23
Diluted Average Shares	0.93% 82.19	82.96	2.7364	82.01	71.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.24

0.66%

INCY

$92.24

1.13%

GMAB

$28.82

0.84%

BNTX

$103.50

0.45%

ONC

$311.64

0.32%

INSM

$181.29

4.26%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters